Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 859076, 7 pages
http://dx.doi.org/10.1155/2012/859076
Review Article

Biomarkers for Hepatocellular Carcinoma

1College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA
2Saint Francis Cancer Treatment Center, Grand Island, NE 68803, USA

Received 16 October 2011; Accepted 27 February 2012

Academic Editor: Neil Guha

Copyright © 2012 Tara Behne and M. Sitki Copur. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [48 citations]

The following is the list of published articles that have cited the current article.

  • Gui Jie Feng, Welwyn Cotta, Xiao Qing Wei, Oliver Poetz, Rebecca Evans, Thierry Jarde, Karen Reed, Valerie Meniel, Geraint T. Williams, Alan R. Clarke, and Trevor C. Dale, “Conditional Disruption of Axin1 Leads to Development of Liver Tumors in Mice,” Gastroenterology, vol. 143, no. 6, pp. 1650–1659, 2012. View at Publisher · View at Google Scholar
  • Haddy K. S. Fye, Cynthia Wright-Drakesmith, Holger B. Kramer, Suzi Camey, Andre Nogueira da Costa, Adam Jeng, Alasana Bah, Gregory D. Kirk, Mohamed I. F. Sharif, Nimzing G. Ladep, Edith Okeke, Pierre Hainaut, Simon D. Taylor-Robinson, Benedikt M. Kessler, and Maimuna E. Mendy, “Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Dominik Bergis, Valentin Kassis, Annika Ranglack, Verena Koeberle, Albrecht Piiper, Bernd Kronenberger, Stefan Zeuzem, Oliver Waidmann, and Heinfried H. Radeke, “High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma,” Translational Oncology, vol. 6, no. 3, pp. 311–318, 2013. View at Publisher · View at Google Scholar
  • Sherif H. Abdeen, Motawa E. EL-Houseini, Mamdouh EL-Sherbiny, Reda Tabashy, and Amany Salah, “Ex vivo assessment of the protective effect of curcumin and taurine against human hepatocarcinogenesis,” The Journal of Basic & Applied Zoology, 2013. View at Publisher · View at Google Scholar
  • Susan Costantini, Francesca Capone, Patrizia Maio, Eliana Guerriero, Giovanni Colonna, Francesco Izzo, and Giuseppe Castello, “Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma,” Oncology Reports, vol. 29, no. 6, pp. 2163–2168, 2013. View at Publisher · View at Google Scholar
  • Wolfgang E. Thasler, Reinhard M. K. Thasler, Celine Schelcher, and Karl-Walter Jauch, “Biobanking for research in surgery: are surgeons in charge for advancing translational research or mere assistants in biomaterial and data preservation?,” Langenbecks Archives Of Surgery, vol. 398, no. 4, pp. 487–499, 2013. View at Publisher · View at Google Scholar
  • Kai Zhu, Zhi Dai, and Jian Zhou, “Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy.,” Biomarker research, vol. 1, no. 1, pp. 10, 2013. View at Publisher · View at Google Scholar
  • Cristiana Iulia Dumitrescu, Daniela Dumitrescu, Daniela Cernea, Corneliu-Cristian Georgescu, and Claudiu Margaritescu, “Hepatocellular carcinoma a retrospective clinico-pathologic and immunohistochemical study of 15 cases,” Revista Romana de Medicina de Laborator, vol. 21, no. 4, pp. 453–464, 2013. View at Publisher · View at Google Scholar
  • Bin Hu, Xiaohui Tian, Jie Sun, and Xiangjun Meng, “Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis,” International Journal of Molecular Sciences, vol. 14, no. 12, pp. 23559–23580, 2013. View at Publisher · View at Google Scholar
  • Howard P. Monsour, Emad Asham, Robert S. McFadden, David W. Victor, Bhuvana Muthuswamy, and Irum Zaheer, “Hepatocellular carcinoma: the rising tide from east to west-a review of epidemiology, screening and tumor markers,” Translational Cancer Research, vol. 2, no. 6, pp. 492–506, 2013. View at Publisher · View at Google Scholar
  • Marko Lempinen, Ilaana Lyytinen, Arno Nordin, Taina Tervahartiala, Heikki Makisalo, Timo Sorsa, and Helena Isoniemi, “Prognostic value of serum MMP-8,-9 and TIMP-1 in patients with hepatocellular carcinoma,” Annals of Medicine, vol. 45, no. 7, pp. 482–487, 2013. View at Publisher · View at Google Scholar
  • Ilana Lyytinen, Marko Lempinen, Arno Nordin, Ulf-Hakan Stenman, Helena Isoniemi, and Heikki Makisalo, “Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-beta (hCG beta) in patients with hepatocellular carcinoma,” Scandinavian Journal Of Gastroenterology, vol. 48, no. 9, pp. 1066–1073, 2013. View at Publisher · View at Google Scholar
  • Maria Daoudaki, and Ioannis Fouzas, “Hepatocellular carcinoma,” Wiener Medizinische Wochenschrift, 2014. View at Publisher · View at Google Scholar
  • Yun Xie, Qinwei Yao, Azeem Mehmood Butt, Jia Guo, Zhou Tian, Xuli Bao, Qing-Hua Meng, Hongxia Li, and Jun Lu, “Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma,” Cancer Biology & Therapy, vol. 15, no. 9, 2014. View at Publisher · View at Google Scholar
  • H.-J. Dai, J. C.-Y. Wu, W.-S. Lin, A. J. F. Reyes, M. A. C. dela Rosa, S. Syed-Abdul, R. T.-H. Tsai, and W.-L. Hsu, “LiverCancerMarkerRIF: a liver cancer biomarker interactive curation system combining text mining and expert annotations,” Database, vol. 2014, no. 0, pp. bau085–bau085, 2014. View at Publisher · View at Google Scholar
  • Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, and Ishtiaq Qadri, “Biomarkers for virus-induced hepatocellular carcinoma (HCC),” Infection, Genetics and Evolution, 2014. View at Publisher · View at Google Scholar
  • Ting-Ting Pan, Wei-Dong Jia, Qi-Yang Yao, Qi-Kai Sun, Wei-Hua Ren, Mei Huang, Jie Ma, Jian-Sheng Li, Jin-Liang Ma, Ji-Hai Yu, Yong-Sheng Ge, Wen-Bin Liu, Chuan-Hai Zhang, and Ge-Liang Xu, “Overexpression of HOXA13 as a Potential Marker for Diagnosis and Poor Prognosis of Hepatocellular Carcinoma,” Tohoku Journal of Experimental Medicine, vol. 234, no. 3, pp. 209–219, 2014. View at Publisher · View at Google Scholar
  • Xia Ying, Yue Zhao, Jun-Lan Wang, Xia Zhou, Jing Zhao, Chen-Chen He, Xi-Jing Guo, Gui-Hua Jin, Li-Juan Wang, Qing Zhu, and Su-Xia Han, “Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma,” Oncology Reports, vol. 32, no. 4, pp. 1550–1556, 2014. View at Publisher · View at Google Scholar
  • Faryal Mehwish Awan, Anam Naz, Ayesha Obaid, Amjad Ali, Jamil Ahmad, Sadia Anjum, and Hussnain Ahmed Janjua, “Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach,” Plos One, vol. 10, no. 9, 2015. View at Publisher · View at Google Scholar
  • Caixia Liu, Haohui Yu, Yan Zhang, Daochuan Li, Xiumei Xing, Liping Chen, Xiaowen Zeng, Dandan Xu, Qiming Fan, Yongmei Xiao, Wen Chen, and Qing Wang, “Upregulation of miR-34a-5p antagonizes AFB1-induced genotoxicity in F344 rat liver,” Toxicon, 2015. View at Publisher · View at Google Scholar
  • Jason Lamontagne, Laura F. Steel, and Michael J. Bouchard, “Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases,” World Journal Of Gastroenterology, vol. 21, no. 24, pp. 7375–7399, 2015. View at Publisher · View at Google Scholar
  • G. Li, Q. Shen, C. Li, D. Li, J. Chen, and M. He, “Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis,” Clinical and Translational Oncology, 2015. View at Publisher · View at Google Scholar
  • Abdelfattah M. Attallah, Mohamed El-Far, Camelia A. Abdel Malak, Mohamed M. Omran, Gamal E. Shiha, Khaled Farid, Lamiaa A. Barakat, Mohamed S. Albannan, Ahmed A. Attallah, Mohamed A. Abdelrazek, Mohamed S. Elbendary, Refaat Sabry, Gehan A. Hamoda, Mohamed M. Elshemy, Abdallah A. Ragab, Basma M. Foda, and Sanaa O. Abdallah, “HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Krishna Beer Singh, Brajesh Kumar Maurya, and Surendra Kumar Trigun, “Activation of oxidative stress and inflammatory factors could account for histopathological progression of aflatoxin-B1 induced hepatocarcinogenesis i,” Molecular And Cellular Biochemistry, vol. 401, no. 1-2, pp. 185–196, 2015. View at Publisher · View at Google Scholar
  • Duo Zuo, Liwei Chen, Xiaoqian Liu, Xia Wang, Qing Xi, Yi Luo, Ning Zhang, and Hua Guo, “Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Po-Li Wei, Chien-Yu Huang, Cheng-Jeng Tai, Uyanga Batzorig, Wan-Li Cheng, Ming-Te Hunag, and Yu-Jia Chang, “Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Chien-Yu Huang, Uyanga Batzorig, Wan-Li Cheng, Ming-Te Huang, Wei- Yu Chen, Po-Li Wei, and Yu-Jia Chang, “Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Simon Chang-Hao Tsao, Andreas Behren, Jonathan Cebon, and Christopher Christophi, “The role of circulating microRNA in hepatocellular carcinoma,” Frontiers In Bioscience-Landmark, vol. 20, pp. 78–104, 2015. View at Publisher · View at Google Scholar
  • Gustavo Ferrín, Patricia Aguilar-Melero, Manuel Rodríguez-Perálvarez, José Luis Montero-Álvarez, and Manuel de la Mata, “Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.,” Hepatic medicine : evidence and research, vol. 7, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Maria Tampaki, “Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights,” World Journal of Hepatology, vol. 7, no. 14, pp. 1834, 2015. View at Publisher · View at Google Scholar
  • Jan Erik Slotta, “Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives,” World Journal of Hepatology, vol. 7, no. 9, pp. 1168, 2015. View at Publisher · View at Google Scholar
  • Ahmed Abdel-Razik, Rania Elhelaly, Rasha Elzehery, Amany El-Diasty, Sally Abed, Dina Elhammady, and Ahmed Tawfik, “Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study,” European Journal of Gastroenterology & Hepatology, vol. 28, no. 5, pp. 599–605, 2016. View at Publisher · View at Google Scholar
  • Amjad Hayat Khan, and Esmaeil Sadroddiny, “Application of immuno-PCR for the detection of early stage cancer,” Molecular and Cellular Probes, 2016. View at Publisher · View at Google Scholar
  • M. S. Chesnokov, O. M. Krivtsova, P. A. Skovorodnikova, A. S. Makarova, I. F. Kustova, M. D. Logacheva, A. A. Penin, A. V. Klepikova, D. A. Shavochkina, N. E. Kudashkin, E. A. Moroz, Y. I. Patyutko, E. A. Kotelnikova, and N. L. Lazarevich, “Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma,” Biopolymers and Cell, vol. 32, no. 6, pp. 418–432, 2016. View at Publisher · View at Google Scholar
  • Bakheet Elsadek, Ahmed Mansour, Tahia Saleem, André Warnecke, and Felix Kratz, “The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib,” Digestive and Liver Disease, 2016. View at Publisher · View at Google Scholar
  • Qi Zhang, Zimu Zhang, Meiyu Peng, Shuyu Fu, Zhenyi Xue, and Rongxin Zhang, “CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: from bench to bedside,” OncoImmunology, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Bérénice Charrière, Charlotte Maulat, Bertrand Suc, and Fabrice Muscari, “Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma,” World Journal of Hepatology, vol. 8, no. 21, pp. 881, 2016. View at Publisher · View at Google Scholar
  • Masayo Tsukamoto, Hidetoshi Nitta, Katsunori Imai, Takaaki Higashi, Shigeki Nakagawa, Hirohisa Okabe, Kota Arima, Takayoshi Kaida, Katsunobu Taki, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Toru Beppu, and Hideo Baba, “Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma,” Hepatology Research, 2017. View at Publisher · View at Google Scholar
  • Yun Hak Kim, Dong Woo Hyun, Sae-Ock Oh, Dae Cheon Jeong, Kyoungjune Pak, Myoung-Eun Han, Ji-Young Kim, Liu Liangwen, Hyun Jin Kim, Tae Woo Kim, and Tae Hwa Kim, “SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma.,” Oncotarget, vol. 8, no. 40, pp. 68381–68392, 2017. View at Publisher · View at Google Scholar
  • Sawsan M Elsonbaty, Walid E Zahran, and Fatma SM Moawed, “Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats,” Tumor Biology, vol. 39, no. 8, pp. 101042831770870, 2017. View at Publisher · View at Google Scholar
  • Dongtai Chen, Yonghua Chen, Yan Yan, Jiahao Pan, Wei Xing, Qiang Li, and Weian Zeng, “Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients,” BMC Cancer, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Wei Dai, Jian Wu, Shuyan Zhang, Bingjie Shi, Xinhui Xu, Danyang Wang, and Jinke Wang, “Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2,” The International Journal of Biochemistry & Cell Biology, 2017. View at Publisher · View at Google Scholar
  • Jinyu Hu, Sugam Sharma, Zhiwei Gao, and Victor Chang, “Gene-based Collaborative Filtering using recommender system,” Computers & Electrical Engineering, 2017. View at Publisher · View at Google Scholar
  • Hala M. F. El Miniawy, Kawkab A. Ahmed, Sameeh A. Mansour, and Marwa M. Salah Khattab, “ In vivo antitumour potential of camel’s milk against hepatocellular carcinoma in rats and its improvement of cisplatin renal side effects ,” Pharmaceutical Biology, vol. 55, no. 1, pp. 1513–1520, 2017. View at Publisher · View at Google Scholar
  • Carole Sourbier, “Plasma HSP90α and liver cancer: a potential biomarker?,” EBioMedicine, 2017. View at Publisher · View at Google Scholar
  • Shuxin Shang, Wei Li, Xue Qin, Shu Zhang, and Yinkun Liu, “Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios.,” Journal of Cancer, vol. 8, no. 5, pp. 887–893, 2017. View at Publisher · View at Google Scholar
  • Sofia Karkampouna, Danny van der Helm, Peter C Gray, Lanpeng Chen, Irena Klima, Joël Grosjean, Mark C Burgmans, Arantza Farina-Sarasqueta, Ewa B Snaar-Jagalska, Deborah M Stroka, Luigi Terracciano, Bart van Hoek, Alexander F Schaapherder, Susan Osanto, George N Thalmann, Hein W Verspaget, Minneke J Coenraad, and Marianna Kruithof-de Julio, “CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma,” The Journal of Pathology, 2018. View at Publisher · View at Google Scholar
  • Nevein M. Al-sheikh, Sally M. El-Hefnway, Ahmed M. Abuamer, and Ashraf G. Dala, “Metadherin mRNA expression in hepatocellular carcinoma,” Egyptian Journal of Medical Human Genetics, 2018. View at Publisher · View at Google Scholar